Search

Yong Peng Lin

from Philadelphia, PA
Age ~49
Get Report
Also known as:
Yong P Lin, Yong L Lin, Yongpeng Lin, Peng Yong Lin, Sheng Yong Lin, Lin P Yong, Lin L Yong, Lin Yongpeng
Phone and address:
1419 S 8Th St, Philadelphia, PA 19147
(215) 336-8866
Related to:
Wen Jing Lin, 34
Connected to:
Abby C Lin, 44Ai H Lin, 74Aidi Lin, 31Alisa Y Lin, 47Alyssa Lin, 39Amy LinAndrea Lin, 51Angelia Lin, 29Angelica B Lin, 52Anhua A Lin, 51

Yong Lin Phones & Addresses

  • 1419 S 8Th St, Philadelphia, PA 19147 (215) 336-8866
  • Millville, NJ
  • Brooklyn, NY
  • New York, NY

Professional Records

Medicine Doctors

Yong Lin Photo 1

Dr. Yong S Lin, New York NY - MD (Doctor of Medicine)

View page
Specialties:
Internal Medicine
Address:
Yong S Lin MD
217 Grand St Suite 301, New York, NY 10013
(212) 226-9717 (Phone)
Certifications:
Internal Medicine, 1996
Awards:
Healthgrades Honor Roll
Languages:
English
Chinese
Education:
Medical School
Nanjing Railway Med Coll
Medical School
Kingsbrook Jewish Medical Center
Yong Lin Photo 2

Dr. Yong Q Lin, Brooklyn NY - MD (Doctor of Medicine)

View page
Specialties:
Rheumatology
Address:
715 68Th St, Brooklyn, NY 11220
(718) 745-9826 (Phone)
Certifications:
Internal Medicine, 2005
Rheumatology, 2008
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
University of Tennessee / Memphis / College of Medicine & Surgery
Graduated: 2002
Yong Lin Photo 3

Yong S. Lin

View page
Specialties:
Internal Medicine
Work:
Yong S Lin MD
217 Grand St STE 301, New York, NY 10013
(212) 226-9717 (phone), (212) 226-9723 (fax)
Education:
Medical School
Southeast Univ Med Coll, Nanjing, Jiangsu, China
Graduated: 1984
Procedures:
Electrocardiogram (EKG or ECG)
Nutrition Therapy
Pulmonary Function Tests
Vaccine Administration
Conditions:
Acne
Acute Upper Respiratory Tract Infections
Atopic Dermatitis
Benign Prostatic Hypertrophy
Calculus of the Urinary System
Languages:
Chinese
English
Description:
Dr. Lin graduated from the Southeast Univ Med Coll, Nanjing, Jiangsu, China in 1984. He works in New York, NY and specializes in Internal Medicine. Dr. Lin is affiliated with New York Presbyterian Lower Manhattan Hospital.
Yong Lin Photo 4

Yong J. Lin

View page
Specialties:
Anesthesiology
Work:
Cedars-Sinai Medical Center Pain Center
444 S San Vicente Blvd STE 1101, Los Angeles, CA 90048
(310) 423-9600 (phone), (310) 423-9610 (fax)
Education:
Medical School
Sun Yat Sen Univ of Med Sci, Guangzhou, China (242 21 Pr 1/71)
Graduated: 1982
Languages:
English
Description:
Dr. Lin graduated from the Sun Yat Sen Univ of Med Sci, Guangzhou, China (242 21 Pr 1/71) in 1982. He works in Los Angeles, CA and specializes in Anesthesiology. Dr. Lin is affiliated with Cedars-Sinai Medical Center.
Yong Lin Photo 5

Yong Jian Lin

View page
Specialties:
Anesthesiology
Pain Medicine
Pain Medicine
Education:
Sun Yat-Sen University (1982)

Public records

Vehicle Records

Yong Lin

View page
Address:
1615 S 6 St, Philadelphia, PA 19148
VIN:
1FTSX21588EB13400
Make:
Ford
Model:
Super Duty F-250
Year:
2008

Resumes

Resumes

Yong Lin Photo 6

Yong Lin

View page
Yong Lin Photo 7

Yong Lin

View page
Yong Lin Photo 8

Yong Lin

View page
Location:
United States
Yong Lin Photo 9

Yong Lin

View page
Location:
United States
Yong Lin Photo 10

Yong Lin Fayetteville, AR

View page
Work:
taiwan
Fayetteville, AR
Mar 2011 to Nov 2014
Driver/Delivery
shee yuan
Philadelphia, PA
Jun 2006 to Mar 2011
Manager, Customer Service
Education:
NWACC
Bentonville, AR
2014 to 2016
current student of NWACC in Enivormental sci
fayetteville high school
Fayetteville, AR
2004 to 2006
high school diploma

Business Records

Name / Title
Company / Classification
Phones & Addresses
Yong Lin
Owner
Great Wall
Eating Place · Restaurants
2234 1 Ave, New York, NY 10029
(212) 426-4888
Yong Q. Lin
Principal
Yong Q Contractor Company
Trade Contractor
1615 S 6 St, Philadelphia, PA 19148
Yong Q. Lin
Principal
Yong Q Lin
Nonclassifiable Establishments
126 Cambridge Rd, Westfield, NJ 07090
Yong Lin
President, Chief Executive Officer
New Eastern Auto Repair, Inc
Automotive Repair
299 305 B Vandervoort Ave, Brooklyn, NY 11211
(347) 245-0820
Yong S. Lin
Vice-President, Internal Medicine, Medical Doctor, Owner
Yong Sheng Lin MD
Health Practitioner's Office
217 Grand St, New York, NY 10013
(212) 226-9717
Yong Xian Lin
Incorporator
YING RESTAURANT, INC
Eating Place
147 Roaring Lion Dr, Hedgesville, WV 25427
2 Mott St STE 505A, New York, NY 10013
(304) 754-8933
Yong S. Lin
Vice-President, Internal Medicine, Medical Doctor, Owner
YONG SHENG LIN, M.D., PLLC
Health Practitioner's Office
217 Grand St 3 FL RM 301, New York, NY 10013
217 Grand St, New York, NY 10013
(212) 226-9717
Yong Lin
LEAP NOVEL TECHNOLOGY, INC

Publications

Isbn (Books And Publications)

Welcome to Singapore

View page
Author

Yong Jui Lin

ISBN #

0836825462

Us Patents

Methods Of Validating Candidate Compounds For Use In Treating Copd And Other Diseases

View page
US Patent:
20100196885, Aug 5, 2010
Filed:
Jan 22, 2008
Appl. No.:
12/449124
Inventors:
Gerard M. Turino - New York NY, US
Yong Y. Lin - Bridgewater NJ, US
Shuren Ma - Cliffside Park NJ, US
Seymour Lieberman - New York NY, US
International Classification:
C12Q 1/68
C12Q 1/00
G01N 33/00
C12Q 1/02
US Classification:
435 6, 435 4, 436 96, 435 29
Abstract:
The present invention relates to methods of diagnosing and treating elastin fiber injuries. In additional preferred embodiments, the present invention relates to methods of validating candidate compounds for use in treating chronic obstructive pulmonary disease (COPD), chronic bronchitis, emphysema, refractory asthma, and other related diseases. Examples of such methods include determining if the candidate compound decreases the degradation of elastic fiber in a patient administered the candidate compound by measuring, using mass spectrometry, a marker of elastic fiber degradation in a sample of a body fluid or a tissue of the patient. The invention provides that a decrease in the presence of the marker compared to a control validates that the candidate compound is effective to treat, prevent, or ameliorate the disease.

Biomarkers For The Treatment Of Psoriasis

View page
US Patent:
20110318741, Dec 29, 2011
Filed:
Jun 15, 2011
Appl. No.:
13/161201
Inventors:
Peter H. SCHAFER - Somerset NJ, US
Yong Lin - Brooklyn NY, US
Donna Sutherland - Green Brook NJ, US
International Classification:
C12Q 1/68
G01N 33/566
US Classification:
435 611, 435 721, 435 724, 435 613, 435 612
Abstract:
Provided herein are the biomarkers for predicting or monitoring the efficacy of a treatment for psoriasis. The use of certain cell markers and mRNA levels as biomarkers to predict whether a psoriasis treatment is likely to be successful is also provided. Further, the expression of these genes or cell markers can be used to monitor progress of treatment effectiveness and patient compliance in psoriasis patients who are receiving treatment.

Methods Of Validating Candidate Compounds For Use In Treating Copd And Other Diseases

View page
US Patent:
20130273586, Oct 17, 2013
Filed:
Mar 15, 2013
Appl. No.:
13/836332
Inventors:
Shuren Ma - Cliffside Park NJ, US
Yong Y. Lin - Bridgewater NJ, US
Seymour Leiberman - New York NY, US
International Classification:
G01N 27/62
US Classification:
435 23, 436 96, 435 29
Abstract:
The present invention relates to methods of diagnosing, monitoring, and treating elastin fiber injuries. In additional preferred embodiments, the present invention relates to methods of validating candidate compounds for use in treating chronic obstructive pulmonary disease (COPD), chronic bronchitis, emphysema, refractory asthma, and other related diseases. Examples of such methods include determining if the candidate compound decreases the degradation of elastic fiber in a patient administered the candidate compound by measuring, using mass spectrometry employing an internal standard, a marker of elastic fiber degradation in a sample of a body fluid or a tissue of the patient. The invention provides that a decrease in the presence of the marker compared to a control validates that the candidate compound is effective to treat, prevent, or ameliorate the disease.

Compositions And Methods For Treating Rheumatoid Arthritis

View page
US Patent:
20190100585, Apr 4, 2019
Filed:
Mar 7, 2017
Appl. No.:
16/082841
Inventors:
- Paris, FR
- Tarrytown NY, US
Neil GRAHAM - Tarrytown NY, US
Yong LIN - Bridgewater NJ, US
Janie PARRINO - Tarrytown NY, US
Rahul PATEL - Bridgewater NJ, US
Janet VAN ADELSBERG - New York NY, US
Hubert VAN HOOGSTRATEN - Bridgewater NJ, US
International Classification:
C07K 16/24
A61P 19/02
C07K 16/28
A61K 39/395
Abstract:
The present invention relates to the use of an anti-IL6 receptor antibody in monotherapy for treating rheumatoid arthritis and for improving the physical function and the quality of life of a subject suffering from rheumatoid arthritis.

Methods Of Validating Candidate Compounds For Use In Treating Copd And Other Diseases

View page
US Patent:
20180172705, Jun 21, 2018
Filed:
Feb 5, 2018
Appl. No.:
15/888959
Inventors:
- New York NY, US
Shuren Ma - Cliffside Park NJ, US
Yong Y. Lin - Bridgewater NJ, US
Seymour Leiberman - , US
International Classification:
G01N 33/68
H01J 49/00
G01N 27/62
G01N 30/72
Abstract:
The present invention relates to methods of diagnosing, monitoring, and treating elastin fiber injuries. In additional preferred embodiments, the present invention relates to methods of validating candidate compounds for use in treating chronic obstructive pulmonary disease (COPD), chronic bronchitis, emphysema, refractory asthma, and other related diseases. Examples of such methods include determining if the candidate compound decreases the degradation of elastic fiber in a patient administered the candidate compound by measuring, using mass spectrometry employing an internal standard, a marker of elastic fiber degradation in a sample of a body fluid or a tissue of the patient. The invention provides that a decrease in the presence of the marker compared to a control validates that the candidate compound is effective to treat, prevent, or ameliorate the disease.

Methods Of Validating Candidate Compounds For Use In Treating Copd And Other Diseases

View page
US Patent:
20150355193, Dec 10, 2015
Filed:
May 14, 2015
Appl. No.:
14/712811
Inventors:
- New York NY, US
Shuren Ma - Cliffside Park NJ, US
Yong Y Lin - Bridgewater NJ, US
Seymour Leiberman - , US
International Classification:
G01N 33/68
G01N 30/72
H01J 49/00
Abstract:
The present invention relates to methods of diagnosing, monitoring, and treating elastin fiber injuries. In additional preferred embodiments, the present invention relates to methods of validating candidate compounds for use in treating chronic obstructive pulmonary disease (COPD), chronic bronchitis, emphysema, refractory asthma, and other related diseases. Examples of such methods include determining if the candidate compound decreases the degradation of elastic fiber in a patient administered the candidate compound by measuring, using mass spectrometry employing an internal standard, a marker of elastic fiber degradation in a sample of a body fluid or a tissue of the patient. The invention provides that a decrease in the presence of the marker compared to a control validates that the candidate compound is effective to treat, prevent, or ameliorate the disease.
Control profile
Yong Peng Lin from Philadelphia, PA, age ~49 Get Report